1. Home
  2. CAKE vs MIRM Comparison

CAKE vs MIRM Comparison

Compare CAKE & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cheesecake Factory Incorporated (The)

CAKE

Cheesecake Factory Incorporated (The)

HOLD

Current Price

$50.09

Market Cap

2.7B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$63.72

Market Cap

3.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CAKE
MIRM
Founded
1972
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
3.4B
IPO Year
1992
2019

Fundamental Metrics

Financial Performance
Metric
CAKE
MIRM
Price
$50.09
$63.72
Analyst Decision
Hold
Strong Buy
Analyst Count
15
11
Target Price
$57.87
$87.55
AVG Volume (30 Days)
1.0M
560.0K
Earning Date
10-28-2025
11-04-2025
Dividend Yield
2.17%
N/A
EPS Growth
24.69
N/A
EPS
3.29
N/A
Revenue
$3,711,211,000.00
$471,794,000.00
Revenue This Year
$6.51
$53.78
Revenue Next Year
$4.67
$19.91
P/E Ratio
$15.16
N/A
Revenue Growth
4.90
53.66
52 Week Low
$42.69
$36.88
52 Week High
$69.70
$78.55

Technical Indicators

Market Signals
Indicator
CAKE
MIRM
Relative Strength Index (RSI) 60.16 33.37
Support Level $46.47 $63.66
Resistance Level $50.62 $66.77
Average True Range (ATR) 1.21 2.93
MACD 0.61 -0.71
Stochastic Oscillator 90.21 3.05

Price Performance

Historical Comparison
CAKE
MIRM

About CAKE Cheesecake Factory Incorporated (The)

Cheesecake Factory Inc owns and operates restaurants in the United States and Canada under brands that include The Cheesecake Factory, North Italia, and a collection within the Fox Restaurants Concepts subsidiary. The company's international presence, in the Middle East and Mexico, is through licensing agreements with third parties. The company also has a bakery division that produces cheesecakes and other baked products for sale in its restaurants, international licensees, and third-party bakery customers. The company has four operating business segments: The Cheesecake Factory restaurants, North Italia, other FRC, and Flower Child. Majority of the company's revenue comes from The Cheesecake Factory restaurants segment.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: